FDA Panel Votes on Fixed-Dose Combination Therapy for ALS
An FDA panel has voted on the question of whether evidence supports the approval of sodium phenylbutyrate/taurursodiol (AMX0035) for ALS.
Stay updated with breaking news from Rating Scale. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
An FDA panel has voted on the question of whether evidence supports the approval of sodium phenylbutyrate/taurursodiol (AMX0035) for ALS.
Post Traumatic Stress Disorder (PTSD) was more common in children who had suffered physical trauma than in adults. Despite its prevalence, the prevalence and factors associated with PTSD in pediatric patients with physical trauma are unknown in Ethiopia. As a result, the purpose of this study was to determine the prevalence of PTSD and associated factors among pediatric patients with physical trauma who attended Northwest Amhara referral hospitals. An institutional-based cross-sectional study design was used in 422 pediatric patients with physical trauma aged 8–18 years from Mar...
Patients with amyotrophic lateral sclerosis carrying variants of the gene glucocerebrosidase were more likely to show cognitive decline compared to noncarriers.
Study finds that low-dose medications for ADHD are not associated with changes in thyroid or growth hormone levels among children aged 6 to 12 years.
NeuroSense CEO Alon Ben-Noon reveals the target patient population and outcome measures of a planned Phase IIb ALS trial of PrimeC.